BACTRIM (sulfamethoxazole; trimethoprim) by PharmaIN is clinical pharmacology bactrim is rapidly absorbed following oral administration. First approved in 1975.
Drug data last refreshed 21h ago · AI intelligence enriched 4d ago
BACTRIM is a fixed-dose combination of sulfamethoxazole and trimethoprim, two synergistic antibacterial agents that inhibit bacterial folate synthesis at sequential steps. Rapidly absorbed orally with peak blood levels achieved 1–4 hours post-administration, the drug is used to treat a broad spectrum of bacterial infections including urinary tract infections, otitis media, and respiratory tract infections. The combination's mechanism leverages dual CYP2C9-mediated metabolism and renal excretion, achieving high urinary concentrations suitable for treating genitourinary infections.
This product is in late-stage lifecycle with minimal Part D activity; career opportunities focus on generic transition management and legacy brand maintenance rather than growth initiatives.
CLINICAL PHARMACOLOGY BACTRIM is rapidly absorbed following oral administration. Both sulfamethoxazole and trimethoprim exist in the blood as unbound, protein-bound and metabolized forms; sulfamethoxazole also exists as the conjugated form. Sulfamethoxazole is metabolized in humans to at least 5…
Worked on BACTRIM at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Non-Interventional Safety Study of Balsamic Bactrim
A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moCareers linked to BACTRIM are primarily in mature-brand stewardship, generic transition management, and regulatory compliance rather than growth or innovation. This product offers stable, foundational pharmaceutical industry experience but limited upside potential; professionals typically use BACTRIM roles as stepping stones to launch-stage or specialty products.